EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
基本信息
- 批准号:6476989
- 负责人:
- 金额:$ 22.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-06-01 至 2003-11-30
- 项目状态:已结题
- 来源:
- 关键词:behavioral /social science research tag clinical research clinical trials community mental health services functional ability health care model health care service evaluation health related legal health services research tag hospital length of stay hospital utilization human subject human therapy evaluation mental disorder diagnosis mental health facility outcomes research outpatient care posthospitalization care psychological tests psychosis rural area social support network substance abuse related disorder therapy compliance
项目摘要
This competing continuation extends the Duke Mental Health Study the first randomized controlled trial (RCT) of the effectiveness of involuntary outpatient commitment (OPC) in reducing rehospitalization and improving outcomes among persons with severe mental illnesses (SMI). OPC is a promising, but controversial legal intervention designed to benefit SMI individuals who need ongoing psychiatric care and support to prevent dangerous relapse and recidivism, but who are SMI individuals who need ongoing psychiatric care and support to prevent dangerous relapse and recidivism, but who are reluctant or have difficulty seeking and following through with community-based treatment. Thirty-eight states and the District of Columbia have explicit OPC statutes. Still, key information is lacking on the advantages and drawbacks of OPC how it exerts its effects, for how long, and for which clinical subgroups. Are the coercive aspects of court-ordered treatment in the community worth the potential benefits to SMI consumers, those who care for them, and to society in general? In the RCT recently completed, involuntarily hospitalized patients awaiting OPC were randomly assigned to continue under OPC upon discharge, or be released from their court order and receive voluntary case management services. Analyses of one-year follow-up data demonstrate that subjects who received sustained periods of OPC and frequent outpatient services had significantly reduced hospitalizations and violent behavior. However, we have yet to (and propose to) examine other key outcomes (symptoms, functioning, substance abuse, homelessness, arrests, family/caregiver strain), and key intervening variables (treatment intensity, medication adherence). Mechanisms underlying OPC must also be examined as well as long-term outcomes post-OPC. Assessment of stakeholders' utilities for this controversial intervention is also needed in order to develop OPC practice guidelines. The goal of this competing continuation application is to address the priorities outlined in the NIMH National Advisory Mental Health Council's Clinical Treatment and Services Workgroup Report. "Bridging Science and Service." We propose to: (1) Extend existing research on OPC's effectiveness by completing ongoing RCT analyses; (2) Gather data about consumers' and other stakeholders' preferences and attitudes regarding OPC; (3) Synthesize all available evidence on OPC effectiveness and utilities for an expert consensus panel charged with developing OPC practice guidelines; and (4) Assess strategies for guideline implementation and design practice improvement research.
这项竞争性的延续扩展了杜克大学心理健康研究的第一个随机对照试验 (RCT),该试验旨在研究非自愿门诊承诺 (OPC) 在减少重度精神疾病 (SMI) 患者的再住院率和改善预后方面的有效性。 OPC 是一种有前途但有争议的法律干预措施,旨在使那些需要持续的精神科护理和支持以防止危险的复发和再犯的 SMI 个体受益,但这些 SMI 个体需要持续的精神科护理和支持以防止危险的复发和再犯,但不愿意或难以寻求和遵循基于社区的治疗。 38 个州和哥伦比亚特区拥有明确的 OPC 法规。尽管如此,关于 OPC 的优点和缺点、如何发挥其作用、持续多长时间以及针对哪些临床亚组,仍缺乏关键信息。法院命令在社区中进行的治疗的强制方面是否值得为 SMI 消费者、照顾他们的人以及整个社会带来潜在利益?在最近完成的随机对照试验中,等待 OPC 的非自愿住院患者被随机分配在出院后继续接受 OPC 治疗,或者解除法院命令并接受自愿案件管理服务。对一年随访数据的分析表明,接受持续 OPC 和频繁门诊服务的受试者住院率和暴力行为显着减少。然而,我们尚未(并建议)检查其他关键结果(症状、功能、药物滥用、无家可归、逮捕、家庭/护理人员压力)和关键干预变量(治疗强度、药物依从性)。还必须检查 OPC 的潜在机制以及 OPC 后的长期结果。为了制定 OPC 实践指南,还需要对利益相关者对这一有争议的干预措施的效用进行评估。这一竞争性延续申请的目标是解决 NIMH 国家心理健康咨询委员会的临床治疗和服务工作组报告中概述的优先事项。 “架起科学与服务的桥梁。”我们建议: (1) 通过完成正在进行的 RCT 分析来扩展 OPC 有效性的现有研究; (2) 收集有关消费者和其他利益相关者对 OPC 的偏好和态度的数据; (3) 为负责制定 OPC 实践指南的专家共识小组综合有关 OPC 有效性和实用性的所有可用证据; (4) 评估指南实施和设计实践改进研究的策略。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Involuntary commitment as a psychiatric technology.
非自愿承诺作为一种精神病学技术。
- DOI:10.1017/s0266462300010904
- 发表时间:1996
- 期刊:
- 影响因子:3.2
- 作者:Hiday,VA
- 通讯作者:Hiday,VA
Consumer perceptions of involuntary outpatient commitment.
消费者对非自愿门诊承诺的看法。
- DOI:10.1176/ps.50.11.1489
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Borum,R;Swartz,M;Riley,S;Swanson,J;Hiday,VA;Wagner,R
- 通讯作者:Wagner,R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARVIN S SWARTZ其他文献
MARVIN S SWARTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARVIN S SWARTZ', 18)}}的其他基金
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
1/2-A 精神分裂症长效注射药物的比较 -ACLAIMS
- 批准号:
8449708 - 财政年份:2009
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
2247960 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
2247962 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
6330258 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
3387709 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
6042241 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
2247961 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
2247958 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
EFFECTIVENESS OF INVOLUNTARY OUTPATIENT COMMITMENT
非自愿门诊承诺的有效性
- 批准号:
2631844 - 财政年份:1992
- 资助金额:
$ 22.81万 - 项目类别:
相似海外基金
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 22.81万 - 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
- 批准号:
10754981 - 财政年份:2023
- 资助金额:
$ 22.81万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10617997 - 财政年份:2022
- 资助金额:
$ 22.81万 - 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
- 批准号:
10538151 - 财政年份:2021
- 资助金额:
$ 22.81万 - 项目类别:
Admin. Supp. for NCI P30 Cancer Center Grants to Facilitate the Development of Standardized Electronic Treatment Plan Builds for NCI-Supported Clinical Trials Applicable Across Clinical Research Sites
行政。
- 批准号:
10442122 - 财政年份:2021
- 资助金额:
$ 22.81万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10624966 - 财政年份:2021
- 资助金额:
$ 22.81万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10515803 - 财政年份:2021
- 资助金额:
$ 22.81万 - 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
- 批准号:
10258627 - 财政年份:2021
- 资助金额:
$ 22.81万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10581505 - 财政年份:2019
- 资助金额:
$ 22.81万 - 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
- 批准号:
10379715 - 财政年份:2019
- 资助金额:
$ 22.81万 - 项目类别: